Harnessing Immunity Against Cancer
How the immune system is becoming cancer's strongest opponent
This journey emerged from 21 new research articles across Medicine, Interdisciplinary and Biology.
This topic surfaced automatically because research activity spiked across multiple disciplines this month.
Cancer has long been treated with surgery, radiation, and chemotherapy—approaches that directly attack tumors. Today, a revolutionary strategy is emerging: training the body's own immune system to recognize and destroy cancer cells. This paradigm shift is transforming outcomes for patients with cancers once considered untreatable.
Recent breakthroughs are making immunotherapy effective against both blood cancers and previously resistant solid tumors. From engineered immune cells to antibodies that redirect the body's defenses, these advances are offering hope where conventional treatments have failed, while research into the gut microbiome and combination therapies promises to expand success rates even further.
The learning journey
Immunotherapy
The foundational concept of using immune systems to fight disease
Cancer treatment
Context for how immunotherapy fits within broader treatment approaches
Bispecific antibody
Engineered proteins that connect immune cells to cancer targets
Acute lymphoblastic leukemia
A blood cancer where bispecific antibodies show dramatic results
CAR T-cell therapy
Advanced cellular engineering now tackling solid tumors
Current research
See the latest discoveries driving this topic below.
Related concepts emerging in this topic
Foundational explainers
What Do We Know About Immunotherapy and Cancer Treatment? A Science-Based Overview
What Do We Know About Immunotherapy and Cancer Treatment? A Science-Based Overview For decades, cancer seemed…
Read →What Do We Know About Cancer Research and Treatment? A Science-Based Overview
Summary: Cancer research has evolved from treating all cases uniformly to precision medicine approaches that target spec…
Read →Research timeline in this topic
Open questions
Science still doesn't fully know:
- Why do some patients respond remarkably to immunotherapy while others with identical cancers show no benefit?
- How can we overcome the immunosuppressive tumor microenvironment that shields solid tumors from engineered immune cells?
- Whether combining immunotherapy with microbiome modulation can predictably enhance treatment outcomes across different cancer types?
Continue exploring